Hemodynamic Bedside Monitoring Instrument with Pressure and Optical Sensors: Validation and Modality Comparison
Source abstract
Abstract
Abstract Results from two independent clinical validation studies for measuring hemodynamics at the patient's bedside using a compact finger probe are reported. Technology comprises a barometric pressure sensor, and in one implementation, additionally, an optical sensor for photoplethysmography (PPG) is developed, which can be used to measure blood pressure and analyze rhythm, including the continuous detection of atrial fibrillation. The capabilities of the technology are shown in several form factors, including a miniaturized version resembling a common pulse oximeter to which the technology could be integrated in. Several main results are presented: i) the miniature finger probe meets the accuracy requirements of non‐invasive blood pressure instrument validation standard, ii) atrial fibrillation can be detected during the blood pressure measurement and in a continuous recording, iii) a unique comparison between optical and pressure sensing mechanisms is provided, which shows that the origin of both modalities can be explained using a pressure‐volume model and that recordings are close to identical between the sensors. The benefits and limitations of both modalities in hemodynamic monitoring are further discussed.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Non-Invasive Vital Sign Monitoring · Hemodynamic Monitoring and Therapy · Heart Rate Variability and Autonomic Control
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Computing University of Turku, Faculty of Technology Vesilinnantie 5 Turku 20500 Finland
Department of Internal Medicine University of Turku Kiinamyllynkatu 4‐8 Turku 20521 Finland
Division of Medicine Turku University Hospital Kiinamyllynkatu 4‐8 Turku 20521 Finland
Funding
Business Finland
References (30)
Show source-provided references
1. 10.1001/jama.2016.1904310.1001/jama.2016.19043 ↗
2. 10.1038/nrdp.2018.1410.1038/nrdp.2018.14 ↗
3. 10.7326/M15-222310.7326/M15-2223 ↗
4. 10.1161/HYP.000000000000008710.1161/HYP.0000000000000087 ↗
5. World health organization hypertension https://www.who.int/news‐room/fact‐sheets/detail/hypertension (accessed: November2022).
6. 10.1161/HYPERTENSIONAHA.120.1502610.1161/HYPERTENSIONAHA.120.15026 ↗
7. 10.1001/jamacardio.2017.142110.1001/jamacardio.2017.1421 ↗
8. 10.1016/j.bja.2021.06.04810.1016/j.bja.2021.06.048 ↗
9. 10.1109/TBME.2015.244195110.1109/TBME.2015.2441951 ↗
10. 10.1109/RBME.2022.314187710.1109/RBME.2022.3141877 ↗
11. 10.1161/CIRCIMAGING.119.00885710.1161/CIRCIMAGING.119.008857 ↗
12. 10.1161/CIRCIMAGING.119.00953110.1161/CIRCIMAGING.119.009531 ↗
13. 10.1016/j.bios.2020.11248310.1016/j.bios.2020.112483 ↗
14. 10.1007/BF0244279810.1007/BF02442798 ↗
15. 10.1126/scitranslmed.aap867410.1126/scitranslmed.aap8674 ↗
16. 10.1038/s41598-018-31632-x10.1038/s41598-018-31632-x ↗
17. Panula T. · medRxiv · 2022
18. 10.1186/1475-925X-11-5610.1186/1475-925X-11-56 ↗
19. 10.1161/01.HYP.21.4.50410.1161/01.HYP.21.4.504 ↗
20. 10.1038/s41746-018-0076-710.1038/s41746-018-0076-7 ↗
21. 10.3389/fpubh.2017.0025810.3389/fpubh.2017.00258 ↗
22. 10.1109/TIM.2023.329387310.1109/TIM.2023.3293873 ↗
23. 10.3390/jcm710031610.3390/jcm7100316 ↗
24. Buekers J. · Eur. Respir. J. · 2018 · 52
25. 10.1038/hr.2012.2610.1038/hr.2012.26 ↗
26. 10.1161/HYPERTENSIONAHA.117.1023710.1161/HYPERTENSIONAHA.117.10237 ↗
27. Topouchian J. · Vasc. Health Risk Manag. · 2011 · 7 · 709
28. Bos W. J. · J. Hypertens. · 2007 · 25 · 4
29. 10.3390/a504058810.3390/a5040588 ↗
30. Kaisti M. · 2017 · 1